Trials / Unknown
UnknownNCT05744076
Analysis of Circulating Exosomes in Melanoma Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis is that PD-L1\[Programmed Death-Ligand 1\] labeling in exosomes could be a biomarker of disease progression in melanoma. The rate of circulating exosomes, their size and the exosomal expression of PD-L1 could be correlated with the stage of the disease, the response to treatment and/or the prognosis of patients. In this study, blood samples (EDTA tubes taken as part of routine care at Besançon University Hospital) and associated clinical data are reused.
Conditions
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2024-03-01
- Completion
- 2024-03-01
- First posted
- 2023-02-24
- Last updated
- 2023-02-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05744076. Inclusion in this directory is not an endorsement.